×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
Yahoo Finance
SALT LAKE CITY, May 20, 2024 (GLOBE NEWSWIRE) -- PolarityTE, a clinical-stage biotechnology company developing regenerative tissue products,...
11 hours ago
PolarityTE Announces First Subject Screened in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE ...
GlobeNewswire
PolarityTE Announces First Subject Screened in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers.
2 months ago
When Can We Expect A Profit From PolarityTE, Inc. (NASDAQ:PTE)?
Yahoo Lifestyle Canada
With the business potentially at an important milestone, we thought we'd take a closer look at PolarityTE, Inc.'s...
5 days ago
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
PR Newswire
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company. PolarityTE (PRNewsfoto/PolarityTE, Inc.) ... PolarityTE, Inc.
16 months ago
PolarityTE Avoids Lawsuit Over Skin Graft Product Disclosures
Bloomberg Law News
PolarityTE Inc. won dismissal of securities fraud allegations involving the approval process for its new skin graft product, SkinTE,...
13 months ago
Polarity TE Announces New Headquarters Relocation to Accommodate Rapid Growth
SLC.gov
Share "Polarity TE Announces New Headquarters Relocation to Accommodate Rapid Growth" to your social network:.
66 months ago
PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?
Forbes
It gives founders the financial incentive (i.e., equity) to walk away from their careers and lead new ventures; and it gives smart investors...
81 months ago
Manufacturing issues force delay for PolarityTE's skin repair hopeful
Fierce Pharma
On its website, PolarityTE describes SkinTE as "donated human tissue for autologous, single application use only." The company manufactures the...
32 months ago
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
PR Newswire
Acceptance of the IND by the FDA enables the Company to commence the first of two expected pivotal studies needed to support a BLA for SkinTE.
21 months ago